drugset / Trial / NCT01406119
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an extension study of ABT-806 for subjects with advanced solid tumors.
Timeline
- Start
- 2011-10
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEPATUXIZUMAB | Monoclonal antibody | — | Intravenous |